Literature DB >> 15009431

Early delayed-type hypersensitivity eosinophil infiltrates depend on T helper 2 cytokines and interferon-gamma via CXCR3 chemokines.

Moe Akahira-Azuma1, Marian Szczepanik, Ryohei F Tsuji, Regis A Campos, Atsuko Itakura, Narciss Mobini, Jennifer McNiff, Ivana Kawikova, Bao Lu, Craig Gerard, Jordan S Pober, Philip W Askenase.   

Abstract

We investigated the role of T helper (Th)1- and Th2-type cytokines in delayed-type hypersensitivity to soluble protein antigens elicited early postimmunization. Mice were sensitized by intradermal injection without adjuvants, or subcutaneously with complete Freund's adjuvant, and subsequently ear challenged intradermally. As soon as day 3, antigen-specific eosinophil-rich responses were elicited in wild-type mice, but not in T-cell receptor-alpha-/- mice without adjuvant. Draining lymph node T cells stimulated with antigen secreted interleukin (IL)-4, IL-5 and interferon-gamma (IFN-gamma). IFN-gamma-dependent specific immunoglobulin G (IgG)2a and IL-4-dependent IgG1 were also generated. Delayed-type hypersensitivity ear swelling and local eosinophil recruitment were decreased in IL-5-/-, IL-4-/- and signal transducer and activator of transcription-6 (STAT-6)-/- mice, and with anti-IL-4 treatment of wild-type mice, suggesting Th2 mechanisms. Interestingly, responses were also decreased in IFN-gamma-/- mice, and IFN-gamma protein and the IFN-gamma-inducible CXC chemokine, IP-10, were present in 24-hr ear tissue extracts, suggesting Th1 effects. Finally, ear swelling, total histology and eosinophils were decreased in mice deficient in CXCR3, the chemokine receptor for IP-10. These results suggest that both a Th2-like (IL-5, IL-4 and STAT-6) and a Th1-like (IFN-gamma, IP-10, CXCR3) pathway contribute to eosinophil recruitment in early delayed-type hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009431      PMCID: PMC1782430          DOI: 10.1111/j.0019-2805.2004.01818.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  Changes in the Th1 or Th2 cytokine dominance in the synovium of rheumatoid arthritis (RA): a kinetic study of the Th subsets in one unusual RA patient.

Authors:  T Aarvak; M Chabaud; J Thoen; P Miossec; J B Natvig
Journal:  Rheumatology (Oxford)       Date:  2000-05       Impact factor: 7.580

2.  CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells.

Authors:  M A García-López; F Sánchez-Madrid; J M Rodríguez-Frade; M Mellado; A Acevedo; M I García; J P Albar; C Martínez; M Marazuela
Journal:  Lab Invest       Date:  2001-03       Impact factor: 5.662

3.  Expression of the Th1 chemokine IFN-gamma-inducible protein 10 in the airway alters mucosal allergic sensitization in mice.

Authors:  R Wiley; K Palmer; B Gajewska; M Stämpfli; D Alvarez; A Coyle; J Gutierrez-Ramos; M Jordana
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

4.  CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma.

Authors:  T Jinquan; C Jing; H H Jacobi; C M Reimert; A Millner; S Quan; J B Hansen; S Dissing; H J Malling; P S Skov; L K Poulsen
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

5.  Eosinophil recruitment into sites of delayed-type hypersensitivity reactions in mice.

Authors:  M M Teixeira; A Talvani; W L Tafuri; N W Lukacs; P G Hellewell
Journal:  J Leukoc Biol       Date:  2001-03       Impact factor: 4.962

6.  Distinct ability to accumulate eosinophils during the inflammatory cellular response to M. bovis BCG in the mouse pleural cavity.

Authors:  E Werneck-Barroso; A C Moura; M M Monteiro; O Menezes de Lima Júnior; M N de Meirelles; M G Henriques
Journal:  Inflamm Res       Date:  2000-05       Impact factor: 4.575

7.  Diagnostic utility of eosinophils in the pleural fluid.

Authors:  M A Martínez-García; E Cases-Viedma; P J Cordero-Rodríguez; M Hidalgo-Ramírez; M Perpiñá-Tordera; F Sanchis-Moret; J L Sanchis-Aldás
Journal:  Eur Respir J       Date:  2000-01       Impact factor: 16.671

8.  Necessity of thromboxane A2 for initiation of platelet-mediated contact sensitivity: dual activation of platelets and vascular endothelial cells.

Authors:  M Mitsuhashi; A Tanaka; C Fujisawa; K Kawamoto; A Itakura; M Takaku; T Hironaka; S Sawada; H Matsuda
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

9.  Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo.

Authors:  T Nishimura; K Iwakabe; M Sekimoto; Y Ohmi; T Yahata; M Nakui; T Sato; S Habu; H Tashiro; M Sato; A Ohta
Journal:  J Exp Med       Date:  1999-09-06       Impact factor: 14.307

10.  Requirement of the chemokine receptor CXCR3 for acute allograft rejection.

Authors:  W W Hancock; B Lu; W Gao; V Csizmadia; K Faia; J A King; S T Smiley; M Ling; N P Gerard; C Gerard
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

View more
  9 in total

1.  Dietary Indoles Suppress Delayed-Type Hypersensitivity by Inducing a Switch from Proinflammatory Th17 Cells to Anti-Inflammatory Regulatory T Cells through Regulation of MicroRNA.

Authors:  Narendra P Singh; Udai P Singh; Michael Rouse; Jiajia Zhang; Saurabh Chatterjee; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2015-12-28       Impact factor: 5.422

2.  Epicutaneous immunization induces alphabeta T-cell receptor CD4 CD8 double-positive non-specific suppressor T cells that inhibit contact sensitivity via transforming growth factor-beta.

Authors:  Marian Szczepanik; Krzysztof Bryniarski; Monika Tutaj; Maria Ptak; Joanna Skrzeczynska; Philip W Askenase; Wlodzimierz Ptak
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

3.  Th1 Immune Response Induction by Biogenic Selenium Nanoparticles in Mice with Breast Cancer: Preliminary Vaccine Model.

Authors:  Mohammad Hossein Yazdi; Mehdi Mahdavi; Elnaz Faghfuri; Mohammad Ali Faramarzi; Zargham Sepehrizadeh; Zuhair Mohammad Hassan; Mehdi Gholami; Ahmad Reza Shahverdi
Journal:  Iran J Biotechnol       Date:  2015-06       Impact factor: 1.671

4.  Adenosine influences myeloid cells to inhibit aeroallergen sensitization.

Authors:  Hong Pei; Joel Linden
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-03-25       Impact factor: 5.464

5.  Subcutaneous late phase responses are augmented during local inhalational tolerance in a murine asthma model.

Authors:  Anurag Singh; Roger S Thrall; Linda A Guernsey; William F Carson; Eric R Secor; Robert E Cone; Thiruchandurai V Rajan; Craig M Schramm
Journal:  Immunol Cell Biol       Date:  2008-05-06       Impact factor: 5.126

6.  Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice.

Authors:  Christin M Lepus; Thomas F Gibson; Scott A Gerber; Ivana Kawikova; Marian Szczepanik; Jaber Hossain; Vitaly Ablamunits; Nancy Kirkiles-Smith; Kevan C Herold; Ruben O Donis; Alfred L Bothwell; Jordan S Pober; Martha J Harding
Journal:  Hum Immunol       Date:  2009-06-12       Impact factor: 2.850

7.  Vasoactive intestinal polypeptide enhances oral tolerance by regulating both cellular and humoral immune responses.

Authors:  Y Wang; Y Mei; S Bao; L Xu
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

8.  Natural Killer Receptor 1 Dampens the Development of Allergic Eosinophilic Airway Inflammation.

Authors:  Shirin Elhaik Goldman; Itay Moshkovits; Avishai Shemesh; Ayelet Filiba; Yevgeny Tsirulsky; Elena Vronov; Marilou Shagan; Ron N Apte; D Aniel Benharroch; Danielle Karo-Atar; Ron Dagan; Ariel Munitz; Yaffa Mizrachi Nebenzahl; Angel Porgador
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240

9.  Therapeutic efficacy and immunological response of CCL5 antagonists in models of contact skin reaction.

Authors:  Miriam Canavese; Fiorella Altruda; Lorenzo Silengo
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.